Sodium Glucuronate Injection
Function and Efficacy
After entering the body, this product is converted into glucuronic acid under the action of enzymes and works to reduce the activity of liver amylase, prevent glycogenolysis, increase liver glycogen content, and reduce fat storage. This product can combine with hydroxyl or carboxyl-containing poisons in the liver and intestines to become low-toxic or non-toxic glucuronic acid conjugates and be excreted in the urine.
Ingredients
Main ingredients: The main ingredient of this product is sodium glucuronate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| D-Glucuronic acid sodium saltIngredients |
After entering the body, this product is converted into glucuronic acid under the action of enzymes and works to reduce the activity of liver amylase, prevent glycogenolysis, increase liver glycogen content, and reduce fat storage. This product can combine with hydroxyl or carboxyl-containing poisons in the liver and intestines to become low-toxic or non-toxic glucuronic acid conjugates and be excreted in the urine. More |
14984-34-0 | 0 |
Appearance
This product is a colorless clear liquid.
Indication
It is used as an auxiliary treatment for acute and chronic hepatitis and cirrhosis. It has an auxiliary effect on liver protection and detoxification in case of food or drug poisoning.
Usage and Dosage
Intramuscular injection: 0.133-0.266g per time, 1-2 times a day; intravenous injection: 0.133-0.266g per time, 1-2 times a day.
Adverse Reactions
No adverse reactions have been reported.
Precautions
It is contraindicated for those who are allergic to this product.
Drug Interactions
Not yet clear.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
2 ml: 0.133 g
Manufacturer
Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
-
Founded in:
1962-12-27 -
Address:
No. 48, North Industrial Avenue, Haizhu District, Guangzhou -
Tax NO.:
9144010119046020XE -
Registered Funds:
46.091897 yuan -
Website:
-
Email: